Cancer modeling in colorectal organoids reveals intrinsic differences between oncogenic RAS and BRAF variants
Post, J. B.; Hami, N.; Lohuis, J.; van de Ven, M.; de Korte-Grimmerink, R.; Stangl, C. S.; Stelloo, E.; Verlaan, I.; van Rheenen, J.; Snippert, H. J. G.
Show abstract
Colorectal cancers (CRCs) with oncogenic mutations in RAS and BRAF are associated with anti-EGFR therapy resistance. Consequently, all RAS mutant CRC patients are being excluded from this therapy. However, heterogeneity in drug response has been reported between RAS mutant CRC patients. It is poorly understood to what extent such differences are derived from different genetic backgrounds or intrinsic differences between the various RAS pathway mutations. Therefore, using CRISPR technology we generated an isogenic panel of patient-derived CRC organoids with various RAS pathway mutations (i.e. KRASG12D, BRAFV600E, KRASG13D and NRASG12D). All RAS pathway mutants promote ERK activation and tumor growth. However, KRASG12D and BRAFV600E mutations in particular conferred robust resistance to anti-EGFR therapy, both in vitro and in vivo. Moreover, untreated KRASG13D mutants showed fastest growth in mice but remained sensitive to anti-EGFR therapy. Together, introducing mutation-specific oncogene signaling in CRC organoids resembles clinical phenotypes and improves understanding of genotype-phenotype correlations.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer 96%
- XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncology 96%
- A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer 96%
Similar papers in this journal
- Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications in a common base culture media system 96%
- A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens 96%
- MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis 95%
Similar papers in this journal
- USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. 95%
- Targeting the cell and non-cell autonomous regulation of 47S synthesis by GCN2 in colon cancer. 95%
- MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation 95%
Similar papers in this journal
- Paradoxical role of AT-rich interactive domain 1A in restraining pancreatic carcinogenesis 96%
- Genome-wide CRISPR screen identifies KEAP1 perturbation as a vulnerability of ARID1A-deficient cells 95%
- Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia 94%
Similar papers in this journal
- Pharmacologically targeting KRASG12D in PDAC models:tumor cell intrinsic and extrinsic impact 96%
- A targetable PREX2/RAC1/PI3Kβ signalling axis confers resistance to clinically relevant therapeutic approaches in melanoma 95%
- SMAD4 and KRAS status shape malignant-stromal crosstalk in pancreatic cancer 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.